Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2026

Conditions

Thyroid CancerNodule Solitary Thyroid

Interventions

DIAGNOSTIC_TEST

Diffuse reflectance spectroscopy

Spectral data collection with diffuse reflectance spectroscopy

Trial Locations (1)

Hammersmith Hospital, London

All Listed Sponsors

lead

Imperial College London

OTHER

NCT07124065 - Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy | Biotech Hunter | Biotech Hunter